1. Home
  2. TOWN vs NVAX Comparison

TOWN vs NVAX Comparison

Compare TOWN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOWN
  • NVAX
  • Stock Information
  • Founded
  • TOWN 1998
  • NVAX 1987
  • Country
  • TOWN United States
  • NVAX United States
  • Employees
  • TOWN N/A
  • NVAX N/A
  • Industry
  • TOWN Major Banks
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TOWN Finance
  • NVAX Health Care
  • Exchange
  • TOWN Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • TOWN 2.6B
  • NVAX 1.4B
  • IPO Year
  • TOWN 1999
  • NVAX 1995
  • Fundamental
  • Price
  • TOWN $33.67
  • NVAX $8.54
  • Analyst Decision
  • TOWN Hold
  • NVAX Hold
  • Analyst Count
  • TOWN 1
  • NVAX 6
  • Target Price
  • TOWN $41.00
  • NVAX $11.33
  • AVG Volume (30 Days)
  • TOWN 342.4K
  • NVAX 4.7M
  • Earning Date
  • TOWN 10-22-2025
  • NVAX 11-11-2025
  • Dividend Yield
  • TOWN 3.20%
  • NVAX N/A
  • EPS Growth
  • TOWN 12.02
  • NVAX N/A
  • EPS
  • TOWN 2.23
  • NVAX 2.54
  • Revenue
  • TOWN $766,599,000.00
  • NVAX $1,078,718,000.00
  • Revenue This Year
  • TOWN $23.98
  • NVAX $61.25
  • Revenue Next Year
  • TOWN $25.35
  • NVAX N/A
  • P/E Ratio
  • TOWN $15.11
  • NVAX $3.35
  • Revenue Growth
  • TOWN 14.10
  • NVAX 9.22
  • 52 Week Low
  • TOWN $29.43
  • NVAX $5.01
  • 52 Week High
  • TOWN $38.28
  • NVAX $11.55
  • Technical
  • Relative Strength Index (RSI)
  • TOWN 46.53
  • NVAX 49.96
  • Support Level
  • TOWN $32.30
  • NVAX $8.19
  • Resistance Level
  • TOWN $34.02
  • NVAX $8.83
  • Average True Range (ATR)
  • TOWN 0.93
  • NVAX 0.44
  • MACD
  • TOWN 0.05
  • NVAX -0.07
  • Stochastic Oscillator
  • TOWN 64.93
  • NVAX 35.44

About TOWN TowneBank

Towne Bank is a financial services company that places special emphasis on serving the financial needs of individuals, commercial enterprises, and professionals, offering retail and commercial banking services to numerous markets in Virginia and North Carolina. The company has three reportable segments: the Banking Segment provides loan and deposit services to retail and commercial customers and provides commercial mortgage brokerage services and investment and asset management services, and the Realty Segment provides residential real estate services and mortgage loans. It also provides resort property management and residential and commercial title insurance, and the Insurance Segment provides a wide array of insurance products, including property, casualty, life, and health insurance.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: